Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 studyPhilip A. Philip, Pascal Hammel, Fabienne Portales et al.|The Lancet. Gastroenterology & hepatology|2020Cited by 249